Skip to Main Content

Go to Main Navigation

Stemina Biomarker Discovery

Year Established:
Madison, Wisconsin, US
Company Type:
Small Business (1-10M TTM Revenue)

Stemina has pioneered development of all human, cell-based tests to screen compounds for their potential to cause birth defects or cardiotoxicity. Our devTOX quickPredict assay is highly predictive of developmental toxicity, as shown in a joint US EPA study published in Toxicological Sciences, and is the only commercially available human-based screen. Our Cardio quickPredict assay assesses structural and functional cardiotoxicity with high accuracy, as published in Toxicological Sciences.

Site Badges
Stemina Biomarker Discovery, Inc.
504 S. Rosa Rd. Madison, Wisconsin, 53719 United States
Stemina Biomarker Discovery
504 S. Rosa Rd. Madison, Wisconsin, 53719 United States

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)